User:Fabio G. Liberante

From OpenWetWare
Jump to navigationJump to search

I am a new member of OpenWetWare!

Contact Info

Fabio G. Liberante
  • Fabio G. Liberante
  • Centre for Cancer Research and Cell Biology
  • Queen's University Belfast
  • 97 Lisburn Road
  • Belfast
  • BT9 7AE
  • Northern Ireland
  • Email me via OpenWetWare

I work in the CCRCB at Queen's University Belfast. My main interests are in the molecular biology of blood cancers. I hope to share my protocols both here and on my own website at CRISPRx.com so that others can benefit.

Education

  • 2012, PhD, Queen's University Belfast
  • 2007, BSc(Hons), Queen's University Belfast

Research interests

  1. Myelodysplastic syndromes and acute myeloid leukaemia
  2. SF3B1
  3. RNA-Seq

Publications

  1. Liberante FG, Pouryahya T, McMullin MF, Zhang SD, and Mills KI. Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia. Oncotarget. 2016 Feb 9;7(6):6609-19. DOI:10.18632/oncotarget.6773 | PubMed ID:26735888 | HubMed [myelodysplasia]

    most recent

  2. Liberante FG, Pellagatti A, Boncheva V, Bowen DT, Mills KI, Boultwood J, and Guinn BA. High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation. Br J Haematol. 2013 Jul;162(2):282-5. DOI:10.1111/bjh.12352 | PubMed ID:23594062 | HubMed [leukaemia]
  3. Dickson GJ, Liberante FG, Kettyle LM, O'Hagan KA, Finnegan DP, Bullinger L, Geerts D, McMullin MF, Lappin TR, Mills KI, and Thompson A. HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy. Haematologica. 2013 Aug;98(8):1216-25. DOI:10.3324/haematol.2012.079012 | PubMed ID:23539541 | HubMed [leukaemia]
  4. Chacko AD, Liberante F, Paul I, Longley DB, and Fennell DA. Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8. BMC Cancer. 2010 Jul 20;10:380. DOI:10.1186/1471-2407-10-380 | PubMed ID:20646307 | HubMed [apoptosis]
  5. Trainor C, Butterworth KT, McGarry CK, Liberante F, O'Sullivan JM, Hounsell AR, and Prise KM. Cell survival responses after exposure to modulated radiation fields. Radiat Res. 2012 Jan;177(1):44-51. DOI:10.1667/rr2656.1 | PubMed ID:22029841 | HubMed [radiation]
  6. Kettyle LM, Liberante FG, and Thompson A. Rational drug repurposing using sscMap analysis in a HOX-TALE model of leukemia. Methods Mol Biol. 2014;1196:349-70. DOI:10.1007/978-1-4939-1242-1_21 | PubMed ID:25151174 | HubMed [methods]

All Medline abstracts: PubMed | HubMed